Sunday, September 13, 2026

Shell Plans 2028 Waterflood at Gulf of Mexico Field as Global Oil Majors Extend Aging Assets

Shell will begin water injection at its Kaikias field in January 2028 to sustain production as reservoir pressure declines, joining a global trend where oil majors prioritize extracting more from existing fields over risky new exploration. The deepwater Gulf of Mexico project can extend production by 3-5 years and recover an additional 10-20% of reserves, mirroring secondary recovery strategies deployed by Equinor in the North Sea and Petrobras offshore Brazil.

ViaNews Editorial Team

February 21, 2026

Source Trace Score1 source document1 with a live linkVerifiability: Basic
Shell Plans 2028 Waterflood at Gulf of Mexico Field as Global Oil Majors Extend Aging Assets
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Shell will begin water injection operations at its Kaikias field in the Gulf of Mexico in January 2028, part of a global shift by oil majors toward squeezing more output from aging fields rather than pursuing frontier exploration. The secondary recovery project targets an additional 10-20% of original oil reserves and can extend plateau production by 3-5 years.

Kaikias started production in 2019 as a subsea tieback to the Ursa hub, 130 miles southeast of New Orleans in water depths exceeding 4,000 feet. The waterflood timeline follows typical deepwater economics, where operators initiate secondary recovery 5-10 years after first oil when production declines 20-40% from peak levels.

The strategy mirrors approaches by international operators managing mature basins. Equinor deploys waterflood at North Sea fields like Johan Sverdrup, while Petrobras uses the technique extensively in Brazil's pre-salt province. Capital discipline and regulatory hurdles make extending existing assets more attractive than developing new discoveries, particularly with oil prices fluctuating between $70-85 per barrel.

Waterflood operations inject water into reservoirs to maintain pressure and push remaining oil toward production wells. Shell's existing Mars Basin infrastructure—including the Olympus, Ursa, and Mars platforms—reduces capital costs compared to standalone developments. The Gulf of Mexico supplies roughly 15% of U.S. crude output, making secondary recovery critical as domestic shale growth slows.

The approach carries technical risks including water breakthrough in production wells, accelerated corrosion, and uncertain reservoir response. Operators must calibrate injection rates to optimize recovery without damaging well integrity or increasing water production that dilutes oil output. Shell's investment reflects industry-wide prioritization of production reliability over growth, with secondary recovery now standard practice across global offshore basins from West Africa to Southeast Asia.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· December 16, 2025
    Shell invests in Kaikias waterflood to unlock production in Gulf of America

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com